Definition
Heyde's syndrome is a medical condition characterized by the coexistence of aortic stenosis and gastrointestinal bleeding, most commonly due to angiodysplasia of the colon. The bleeding is attributed to an acquired deficiency of high‑molecular‑weight von Willebrand factor (vWF) caused by shear stress across the stenotic aortic valve.
Overview
Patients with severe aortic stenosis may develop chronic, occult, or overt gastrointestinal hemorrhage. The pathophysiology involves high shear forces generated by the narrowed aortic valve, which lead to proteolytic cleavage of vWF multimers. This acquired type 2A von Willebrand disease reduces platelet adhesion at sites of mucosal vascular lesions, particularly angiodysplastic lesions, resulting in bleeding. Management typically addresses both components: correction of aortic stenosis (e.g., surgical valve replacement or transcatheter aortic valve implantation) often reduces or resolves the gastrointestinal bleeding, while hemostatic measures may be employed in the interim.
Etymology/Origin
The eponym derives from Dr. Edward “Ted” Heyde, a German cardiac surgeon who, along with collaborators, first described the clinical association in the 1950s and 1960s. The term entered the medical literature in the 1970s and has since been used to denote this specific interplay between valvular heart disease and bleeding.
Characteristics
- Primary cardiac lesion: Severe calcific aortic stenosis, usually of degenerative origin.
- Gastrointestinal manifestation: Chronic or intermittent bleeding, often from colonic angiodysplasia; may present as iron‑deficiency anemia, melena, or overt hematochezia.
- Laboratory findings: Reduced ristocetin co‑factor activity, loss of high‑molecular‑weight vWF multimers, normal platelet count.
- Diagnostic approach: Echocography to assess aortic valve area and gradient; endoscopic evaluation (colonoscopy) to identify angiodysplastic lesions; von Willebrand factor assays to confirm functional deficiency.
- Therapeutic considerations: Aortic valve replacement (surgical or transcatheter) is the definitive treatment; adjunctive therapies may include iron supplementation, desmopressin, or vWF concentrates for acute bleeding episodes.
Related Topics
- Aortic stenosis
- Angiodysplasia
- Acquired von Willebrand disease (type 2A)
- Gastrointestinal bleeding
- Transcatheter aortic valve implantation (TAVI)
- Hemostasis and platelet function disorders